Literature DB >> 14716309

Identification of amino acid residues crucial for chemokine receptor dimerization.

Patricia Hernanz-Falcón1, José Miguel Rodríguez-Frade, Antonio Serrano, David Juan, Antonio del Sol, Silvia F Soriano, Fernando Roncal, Lucio Gómez, Alfonso Valencia, Carlos Martínez-A, Mario Mellado.   

Abstract

Chemokines coordinate leukocyte trafficking by promoting oligomerization and signaling by G protein-coupled receptors; however, it is not known which amino acid residues of the receptors participate in this process. Bioinformatic analysis predicted that Ile52 in transmembrane region-1 (TM1) and Val150 in TM4 of the chemokine receptor CCR5 are key residues in the interaction surface between CCR5 molecules. Mutation of these residues generated nonfunctional receptors that could not dimerize or trigger signaling. In vitro and in vivo studies in human cell lines and primary T cells showed that synthetic peptides containing these residues blocked responses induced by the CCR5 ligand CCL5. Fluorescence resonance energy transfer showed the presence of preformed, ligand-stabilized chemokine receptor oligomers. This is the first description of the residues involved in chemokine receptor dimerization, and indicates a potential target for the modification of chemokine responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14716309     DOI: 10.1038/ni1027

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  58 in total

Review 1.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.

Authors:  Wen Guo; Lei Shi; Marta Filizola; Harel Weinstein; Jonathan A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

Review 3.  Co-evolution analysis on endocrine research: a methodological approach.

Authors:  Tonghai Dou; Shuai Chen; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

4.  Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling.

Authors:  Xuanmao Jiao; Ning Zhang; Xuehua Xu; Joost J Oppenheim; Tian Jin
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 5.  The specificity and molecular basis of alpha1-adrenoceptor and CXCR chemokine receptor dimerization.

Authors:  Graeme Milligan; Shirley Wilson; Juan F López-Gimenez
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Entropy and oligomerization in GPCRs.

Authors:  Rajkumar P Thummer; Matthew P Campbell; Mark K Dean; Marie J Frusher; Paul D Scott; Christopher A Reynolds
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

7.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

Review 8.  The attraction of chemokines as a target for specific anti-inflammatory therapy.

Authors:  James E Pease; Timothy J Williams
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

9.  Biophysical and structural investigation of bacterially expressed and engineered CCR5, a G protein-coupled receptor.

Authors:  Maciej Wiktor; Sébastien Morin; Hans-Jürgen Sass; Fabian Kebbel; Stephan Grzesiek
Journal:  J Biomol NMR       Date:  2012-12-11       Impact factor: 2.835

10.  Rhodopsin signaling and organization in heterozygote rhodopsin knockout mice.

Authors:  Yan Liang; Dimitrios Fotiadis; Tadao Maeda; Akiko Maeda; Anna Modzelewska; Slawomir Filipek; David A Saperstein; Andreas Engel; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.